CHF Inpatient Ambulation Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
By implementing an ambulatory study, the goal is to decrease the hospital length of stay by half of a day, decrease the percentage of patients being discharged to an extended nursing care facility, and improve quality of life for the patient. Fiscal year 2014 the average length of stay for a CHF patient at Lancaster General Health was 6.0, and as of fiscal year 2015 this was decreased to 5.8. According to Harlan M Krumbholz's theory of post hospital syndrome, patients are subjected to a time of increased risk of impaired stamina, coordination, strength and readmission for about thirty days after discharge due to deconditioning during their hospitalization. By implementing the ambulatory study, the hope is to prevent such extensive deconditioning to help improve the patient's quality of life after discharge; thereby reducing length of stay, discharges to skilled nursing facilities, 30 day readmissions and costs.
The advent of wearable activity and/or health monitors in the health and fitness industry segment has the potential to revolutionize the industry. More importantly, these devices allow new variables to be collected to provide an impact on patients' care and outcome such as steps taken per day.
The intention of the ambulation study is to prevent hospital acquired deconditioning; which in turn would not only decrease the length of stay, but also improve the discharge disposition and place them at home rather than hospice, an extended care facility or rehab. Not only is the intent of the study to decrease the length of stay and also improve the patient's disposition, but also improve their quality of life. In addition, the study will test the effectiveness of the addition of a mobility aide to assist with patients walking on the nursing units.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Lancaster, Pennsylvania, United States, 17604
- Lancaster General Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Diagnosis of heart failure
- The heart group as attending or consultant
- Patient on 5 West at the time of admission
- Admission diagnosis of heart failure
- Age ≥ 18
- Initial assessment completed within 10 hours of admission by a registered nurse
Exclusion Criteria:
- Patient admitted from acute rehabilitation or skilled nursing facility
- Altered weight bearing or unable to complete initial 2 minute walk test
- Unwilling or unable to participate or consent
- Acute delirium or dementia by history
- Hospice or actively dying
- Ventricular assist device or listed for heart transplantation
- Inotrope dependence
- Active ischemia
- Heart rate (HR) <50 or >130 at rest
- Blood pressure (BP) <80 or >180 at rest
- Pulse oximetry <88% at rest
- Patient is in isolation for multi-drug resistant organism such as MRSA or C-diff
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Control Group - Usual Care
At the start of the study, subjects will be enrolled in usual care when admitted to the heart failure unit following standard protocols.
|
|
|
Intervention Group - Aggressive Ambulation
After a washout period and transition to a new aggressive ambulation protocol, subjects will be enrolled to usual care + aggressive planned ambulation with a trained mobility aide.
|
A trained mobility aide will provide aggressive ambulation at least 3X per day for all patients on the heart failure unit
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Walk distance
Time Frame: Through study completion, an average of 5 days
|
Walk distance using a 2-minute walk test will be assessed at admission and again at discharge. A clear starting and stopping point will be made with distance marked every 10 feet. A chair with armrests will be at the starting and stopping point of the walk distance. The designated area will be between 5 East and 5 West which will be standard for each patient. After the assessment the nurse will document the total patient's distance to the nearest 10 feet. Example "Ms. Smith walked 100 feet with 3 stops in 2 minutes." The patient will have a repeat 2 minute walk test on the day of discharge using the same criteria. For the walk test:
|
Through study completion, an average of 5 days
|
|
Steps per day
Time Frame: Through study completion, an average of 5 days
|
Steps per day for each day in the hospital will be measured in 15-minute intervals from admission to discharge using a Fitbit device (wearable device on the wrist).
Data will be downloaded from the Fitbit upon discharge.
|
Through study completion, an average of 5 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Disposition at Discharge
Time Frame: At discharge/completion of study; an average of 5 days after admission
|
Discharge disposition to home, skilled care/nursing care, etc. will be tracked.
|
At discharge/completion of study; an average of 5 days after admission
|
|
Readmission within 30 days
Time Frame: 30 Days after discharge
|
Readmission within 30 days of discharge
|
30 Days after discharge
|
|
Falls
Time Frame: Through study completion, an average of 5 days
|
Record any falls or near falls for subjects enrolled in the study during hospital stay from admission to discharge
|
Through study completion, an average of 5 days
|
|
Length of Stay
Time Frame: Through study completion, an average of 5 days
|
Calculation of length of stay from hour/day of admission to hour/day of discharge
|
Through study completion, an average of 5 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Justin Roberts, DO, Lancaster General Hospital
- Principal Investigator: Lisa Rathman, CRNP, Lancaster General Hospital
- Principal Investigator: Dana Irwin, BSN, RN, Lancaster General Hospital
- Principal Investigator: Michael Killinger, MSN, RN, Lancaster General Hospital
- Principal Investigator: Nathaniel Baker, DPT, Lancaster General Hospital
- Principal Investigator: Michael Horst, PhD, Lancaster General Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CHF Inpatient Ambulation Trial
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.